~ Buy the SODIUM CHLORIDE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Sodium chloride - Generic Drug Details

What are the generic sources for sodium chloride and what is the scope of freedom to operate?

Sodium chloride is the generic ingredient in fourteen branded drugs marketed by Blairex, Abbott, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Icu Medical Inc, Miles, Medefil Inc, Fresenius Medcl, Haemonetics, Laboratorios Grifols, Liebel-flarsheim, Abraxis Pharm, Hikma, Nexus Pharms, Spectra Mdcl Devices, Jubilant Cadista, Nephron, and Taro, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for sodium chloride. Twenty-five suppliers are listed for this compound.

Summary for sodium chloride

US Patents:	0
Tradenames:	14
Applicants:	20
NDAs:	56
Drug Master File Entries:	19
Finished Product Suppliers / Packagers:	25
Raw Ingredient (Bulk) Api Vendors:	328
Patent Applications:	6,070
Drug Prices:	Drug price trends for sodium chloride
What excipients (inactive ingredients) are in sodium chloride?	sodium chloride excipients list
DailyMed Link:	sodium chloride at DailyMed

See drug prices for sodium chloride

See drug sales revenues for sodium chloride

Pharmacology for sodium chloride

Drug Class	Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Anatomical Therapeutic Chemical (ATC) Classes for sodium chloride

A12CA	Sodium
A12C	OTHER MINERAL SUPPLEMENTS
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

B05CB	Salt solutions
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

B05XA	Electrolyte solutions
B05X	I.V. SOLUTION ADDITIVES
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

US Patents and Regulatory Information for sodium chloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medefil Inc	SODIUM CHLORIDE 0.9%	sodium chloride	INJECTABLE;INJECTION	202832-005	Jan 6, 2012		DISCN	Yes	No
Hospira	SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;IRRIGATION	018380-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Icu Medical Inc	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	019217-003	Nov 18, 1998		DISCN	Yes	No
Hospira	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	018803-006	Jan 22, 2015		DISCN	Yes	No
Hospira	SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	sodium chloride	SOLUTION;INJECTION	019465-001	Jul 15, 1985	AP	RX	Yes	Yes
Medefil Inc	SODIUM CHLORIDE 0.9%	sodium chloride	INJECTABLE;INJECTION	202832-004	Jan 6, 2012		DISCN	Yes	No
B Braun	SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	sodium chloride	INJECTABLE;INJECTION	018184-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Sodium chloride Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Pharmaceutical Grade Sodium Chloride

Introduction

Pharmaceutical grade sodium chloride, commonly known as medicinal salt, is a crucial component in various medical and pharmaceutical applications. This article delves into the market dynamics, financial trajectory, and key factors influencing the growth of the pharmaceutical grade sodium chloride market.

Market Size and Forecast

The pharmaceutical grade sodium chloride market is projected to experience significant growth over the coming years. As of 2024, the market is valued at approximately USD 355 million and is expected to reach USD 618 million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 5.70% from 2024 to 2034[1].

Historical Growth

Historically, the market has grown at a CAGR of 3.20% from 2019 to 2023. However, the growth rate has accelerated, reflecting increased demand and new applications in the healthcare sector[1].

Regional Market Dynamics

United States

The United States is anticipated to hold a CAGR of 3.20% from 2024 to 2034. The strong healthcare infrastructure and substantial investments in research and development in the pharmaceutical and healthcare sectors drive this growth. The U.S. market is expected to benefit from the need for continued research and development, particularly in treating resistant illnesses[1].

China

China is on the verge of significant market expansion, with a projected CAGR of 6.30% from 2024 to 2034. The growing population, government emphasis on improving healthcare, and increasing access to quality healthcare are key drivers. China is poised to become one of the most significant global pharmaceutical markets, despite currently holding a slim share[1].

India and Other Emerging Markets

India, along with other emerging markets like Japan and Brazil, is focusing on pharmaceutical development, which is expected to drive the demand for pharmaceutical grade sodium chloride. These regions are expected to contribute significantly to the market growth due to their growing expenditure on pharmaceutical manufacturing[4].

Applications and End-Use Industries

Medical Treatments

Pharmaceutical grade sodium chloride is widely used in maintaining blood pressure, cleaning medical equipment, and as an ingredient in various pharmaceutical formulations. The increasing rates of medical treatments for patients with resistant illnesses further highlight the need for this product[1].

Irrigation Solutions

Sodium chloride irrigation solutions are used in hospitals, clinics, and other healthcare settings. The market for these solutions is expected to grow at a CAGR of 3 to 5 percent from 2024 to 2031, driven by the demand for sterile and safe medical solutions[2].

Challenges and Barriers

The production of pharmaceutical grade sodium chloride requires high purity standards, which can be a significant barrier for small and medium-sized manufacturers. High production and sales expenditures limit market entry for new players, giving larger companies a dominant position[1].

Competitive Landscape

Major Players

Key players in the market are investing heavily in research and development, increasing manufacturing capacity, and launching new products. Companies like Baxter, Fresenius Kabi, and Bbraun are prominent in the market, promoting their products through advanced technologies and marketing strategies[2].

Strategic Collaborations

There is a significant focus on strategic collaborations with end-users and regional distributors to address the needs of a developing customer base. Robust partnerships throughout the value chain and strong research and development activities are driving market expansion[1].

Impact of the Global Pandemic

The global pandemic has had a significant impact on the pharmaceutical grade sodium chloride market. Lockdown regulations reduced end-product consumption, but the market is expected to recover and experience rapid growth due to increased consumption and future applications[1].

Financial Trajectory

Revenue Growth

The market is expected to grow from USD 355 million in 2024 to USD 618 million by 2034, indicating a substantial increase in revenue over the forecast period[1].

Investment and Expansion

Major players are ramping up their efforts to meet the growing demand by investing in research and development, manufacturing capacity, and innovative products. This investment is expected to drive the financial growth of the market[1].

Key Takeaways

• The pharmaceutical grade sodium chloride market is valued at USD 355 million in 2024 and is expected to reach USD 618 million by 2034.
• The market is growing at a CAGR of 5.70% from 2024 to 2034.
• Regional markets, particularly in the United States and China, are driving growth due to strong healthcare infrastructure and government initiatives.
• High purity production requirements and sales expenditures are significant barriers for new market entrants.
• Major players are investing in research and development, manufacturing capacity, and strategic collaborations to drive market growth.

FAQs

Q: What is the projected CAGR for the pharmaceutical grade sodium chloride market from 2024 to 2034? A: The market is expected to grow at a CAGR of 5.70% from 2024 to 2034[1].

Q: Which region is expected to experience the highest growth rate in the pharmaceutical grade sodium chloride market? A: China is expected to experience the highest growth rate with a CAGR of 6.30% from 2024 to 2034[1].

Q: What are the primary applications of pharmaceutical grade sodium chloride? A: It is used in maintaining blood pressure, cleaning medical equipment, and as an ingredient in various pharmaceutical formulations[1].

Q: How has the global pandemic impacted the pharmaceutical grade sodium chloride market? A: The pandemic reduced end-product consumption but is expected to recover with rapid growth due to increased consumption and future applications[1].

Q: Which companies are major players in the pharmaceutical grade sodium chloride market? A: Companies like Baxter, Fresenius Kabi, and Bbraun are prominent in the market[2].

Sources

1. Future Market Insights - Pharmaceutical Grade Sodium Chloride Market Analysis to 2034
2. Market Research Intellect - Sodium Chloride Irrigation Solution Market Size And Forecast
3. Verified Market Research - Sodium Chloride Market Size Share, Growth, Analysis & Forecast
4. Maximize Market Research - Pharmaceutical Grade Sodium Chloride Market- (2023-2029)
5. PR Newswire - Global Sodium Chloride (Salt) Market to Reach $19.2 Billion by 2026